Ascendis Pharma A/S Balance Sheet Statement

ASND $121.95 -2.2 -1.8%

16/04/21

Adventurous, Large Cap, Sucker Stock

Market Cap £4.74bn

Enterprise Value £4.20bn

Revenue £6.02m

Quality

Value

Momentum

StockRank™

To unlock Ascendis Pharma A/S's balance sheet statement please upgrade your membership.

	2015	2016	2017	2018	2019	2020
Period End:	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31
Period Length:	0	0	0	0	0	0
Currency:	EUR	EUR	EUR	EUR	EUR	EUR

Cash & Equivalents
Short Term Investments
Cash and Short Term Investments
Accounts Receivable - Trade, Net
Total Receivables, Net
Prepaid Expenses
Other Current Assets, Total
Total Current Assets

Property/Plant/Equipment, Total - Gross
Accumulated Depreciation, Total
Property/Plant/Equipment, Total - Net
Goodwill, Net
Intangibles, Net
Long Term Investments
Note Receivable - Long Term
Other Long Term Assets, Total
Total Assets

Accounts Payable
Payable/Accrued
Notes Payable/Short Term Debt
Current Port. of LT Debt/Capital Leases
Other Current Liabilities, Total
Total Current Liabilities

Capital Lease Obligations
Total Long Term Debt
Total Debt
Other Liabilities, Total
Total Liabilities

Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity, Total
Total Equity

Total Liabilities & Shareholders’ Equity
Total Common Shares Outstanding

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.